17-39666026-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_003673.4(TCAP):āc.421C>Gā(p.Pro141Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000584 in 1,610,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. P141P) has been classified as Benign.
Frequency
Consequence
NM_003673.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCAP | NM_003673.4 | c.421C>G | p.Pro141Ala | missense_variant | 2/2 | ENST00000309889.3 | NP_003664.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCAP | ENST00000309889.3 | c.421C>G | p.Pro141Ala | missense_variant | 2/2 | 1 | NM_003673.4 | ENSP00000312624.2 | ||
TCAP | ENST00000578283.1 | c.349C>G | p.Pro117Ala | missense_variant | 3/3 | 5 | ENSP00000462787.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000323 AC: 8AN: 247926Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134658
GnomAD4 exome AF: 0.0000624 AC: 91AN: 1458470Hom.: 0 Cov.: 30 AF XY: 0.0000730 AC XY: 53AN XY: 725768
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74348
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 30, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 21, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 20215591, 19412328, 29884292, 18585512, 16911908) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 08, 2021 | The p.P141A variant (also known as c.421C>G), located in coding exon 2 of the TCAP gene, results from a C to G substitution at nucleotide position 421. The proline at codon 141 is replaced by alanine, an amino acid with highly similar properties. This alteration has been detected in an individual with dilated cardiomyopathy who also has variants in other cardiac-related genes. The p.P141A alteration reportedly did not segregate with disease; however, details regarding segregation were limited (Hershberger RE et al. Circ Cardiovasc Genet. 2010;3:155-61). This variant was also detected in a sudden cardiac arrest cohort (Giudicessi JR. Int J Cardiol. 2018 Nov;270:214-220). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Primary familial hypertrophic cardiomyopathy;C4225408:Hypertrophic cardiomyopathy 25 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2023 | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 141 of the TCAP protein (p.Pro141Ala). This variant is present in population databases (rs45509691, gnomAD 0.005%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 19412328, 20215591). ClinVar contains an entry for this variant (Variation ID: 180535). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Benign:1
Likely benign, no assertion criteria provided | clinical testing | Blueprint Genetics | Jun 16, 2014 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2G;C4225408:Hypertrophic cardiomyopathy 25 Other:1
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpretted as Uncertain significance and reported on 08/01/2018 by GTR ID EGL Genetics. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at